PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ENB vs. NVS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ENB and NVS is 0.31, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

ENB vs. NVS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Enbridge Inc. (ENB) and Novartis AG (NVS). The values are adjusted to include any dividend payments, if applicable.

-10.00%0.00%10.00%20.00%30.00%AugustSeptemberOctoberNovemberDecember2025
26.33%
-11.39%
ENB
NVS

Key characteristics

Sharpe Ratio

ENB:

2.01

NVS:

-0.26

Sortino Ratio

ENB:

2.86

NVS:

-0.25

Omega Ratio

ENB:

1.34

NVS:

0.97

Calmar Ratio

ENB:

1.34

NVS:

-0.21

Martin Ratio

ENB:

9.82

NVS:

-0.51

Ulcer Index

ENB:

2.96%

NVS:

8.44%

Daily Std Dev

ENB:

14.48%

NVS:

16.22%

Max Drawdown

ENB:

-46.35%

NVS:

-41.72%

Current Drawdown

ENB:

0.00%

NVS:

-18.05%

Fundamentals

Market Cap

ENB:

$96.55B

NVS:

$198.44B

EPS

ENB:

$2.04

NVS:

$5.73

PE Ratio

ENB:

21.73

NVS:

17.29

PEG Ratio

ENB:

2.17

NVS:

2.96

Total Revenue (TTM)

ENB:

$37.19B

NVS:

$37.51B

Gross Profit (TTM)

ENB:

$13.92B

NVS:

$27.93B

EBITDA (TTM)

ENB:

$13.66B

NVS:

$15.56B

Returns By Period

In the year-to-date period, ENB achieves a 4.48% return, which is significantly higher than NVS's 1.81% return. Both investments have delivered pretty close results over the past 10 years, with ENB having a 5.37% annualized return and NVS not far ahead at 5.63%.


ENB

YTD

4.48%

1M

6.74%

6M

26.33%

1Y

29.78%

5Y*

9.08%

10Y*

5.37%

NVS

YTD

1.81%

1M

1.33%

6M

-11.39%

1Y

-4.49%

5Y*

6.05%

10Y*

5.63%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ENB vs. NVS — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ENB
The Risk-Adjusted Performance Rank of ENB is 9090
Overall Rank
The Sharpe Ratio Rank of ENB is 9494
Sharpe Ratio Rank
The Sortino Ratio Rank of ENB is 9191
Sortino Ratio Rank
The Omega Ratio Rank of ENB is 8888
Omega Ratio Rank
The Calmar Ratio Rank of ENB is 8686
Calmar Ratio Rank
The Martin Ratio Rank of ENB is 9292
Martin Ratio Rank

NVS
The Risk-Adjusted Performance Rank of NVS is 3232
Overall Rank
The Sharpe Ratio Rank of NVS is 3535
Sharpe Ratio Rank
The Sortino Ratio Rank of NVS is 2727
Sortino Ratio Rank
The Omega Ratio Rank of NVS is 2727
Omega Ratio Rank
The Calmar Ratio Rank of NVS is 3535
Calmar Ratio Rank
The Martin Ratio Rank of NVS is 3939
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ENB vs. NVS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Enbridge Inc. (ENB) and Novartis AG (NVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ENB, currently valued at 2.01, compared to the broader market-2.000.002.002.01-0.26
The chart of Sortino ratio for ENB, currently valued at 2.86, compared to the broader market-4.00-2.000.002.004.002.86-0.25
The chart of Omega ratio for ENB, currently valued at 1.34, compared to the broader market0.501.001.502.001.340.97
The chart of Calmar ratio for ENB, currently valued at 1.34, compared to the broader market0.002.004.006.001.34-0.21
The chart of Martin ratio for ENB, currently valued at 9.82, compared to the broader market-30.00-20.00-10.000.0010.0020.009.82-0.51
ENB
NVS

The current ENB Sharpe Ratio is 2.01, which is higher than the NVS Sharpe Ratio of -0.26. The chart below compares the historical Sharpe Ratios of ENB and NVS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.002.503.00AugustSeptemberOctoberNovemberDecember2025
2.01
-0.26
ENB
NVS

Dividends

ENB vs. NVS - Dividend Comparison

ENB's dividend yield for the trailing twelve months is around 6.01%, more than NVS's 3.81% yield.


TTM20242023202220212020201920182017201620152014
ENB
Enbridge Inc.
6.01%6.28%7.29%6.79%6.86%7.56%5.57%6.69%4.73%3.78%4.41%2.47%
NVS
Novartis AG
3.81%3.88%3.44%3.91%4.08%3.40%2.87%3.72%3.50%4.06%3.51%3.14%

Drawdowns

ENB vs. NVS - Drawdown Comparison

The maximum ENB drawdown since its inception was -46.35%, which is greater than NVS's maximum drawdown of -41.72%. Use the drawdown chart below to compare losses from any high point for ENB and NVS. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%0.00%AugustSeptemberOctoberNovemberDecember20250
-18.05%
ENB
NVS

Volatility

ENB vs. NVS - Volatility Comparison

Enbridge Inc. (ENB) has a higher volatility of 4.42% compared to Novartis AG (NVS) at 4.07%. This indicates that ENB's price experiences larger fluctuations and is considered to be riskier than NVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%7.00%AugustSeptemberOctoberNovemberDecember2025
4.42%
4.07%
ENB
NVS

Financials

ENB vs. NVS - Financials Comparison

This section allows you to compare key financial metrics between Enbridge Inc. and Novartis AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab